Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Experimental Oncology
  • Published:

Human angiogenin, an organogenic protein

Abstract

Angiogenin is a 14 kD protein, initially isolated as a tumour-cell secreted product but subsequently found to be a normal constituent of human plasma. It is a potent inducer of blood vessel formation on the chorioallantoic membrane of the chick embryo. Chemical characterization of the protein reveals a remarkable homology to the pancreatic ribonuclease family and has led to the identification of a unique ribonucleolytic activity for angiogenin. It is a particularly potent inhibitor of in vitro protein synthesis. Treatment with placental ribonuclease inhibitor abolishes the biological and enzymatic activities of angiogenin, an effect with important mechanistic, physiological and pharmacologic implications.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Presented, by invitation, at the BACR/CRC/ICRF Symposium in 'Growth factors', London, December 1987.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Riordan, J., Vallee, B. Human angiogenin, an organogenic protein. Br J Cancer 57, 587–590 (1988). https://doi.org/10.1038/bjc.1988.133

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1988.133

Search

Quick links